Summary:
- The article discusses the potential of generative AI to transform the pharmaceutical industry, both in the present and the coming years.
- Generative AI models like GPT-3 and DALL-E can be used to accelerate drug discovery, optimize manufacturing processes, and improve patient engagement and communication.
- Experts predict that generative AI will become an integral part of the pharmaceutical industry's toolbox, enabling faster innovation, increased efficiency, and better patient outcomes.